Company intelligence
Cancer Research Institute (CRI)
Advancing cancer immunotherapy through rigorous scientific research, global collaboration, and innovation.
About Cancer Research Institute (CRI)
The Cancer Research Institute (CRI) is a nonprofit organization exclusively focused on advancing cancer immunotherapy through rigorous scientific research, global collaboration, and data-driven innovation. Since 1953, CRI has empowered researchers to uncover how the immune system can fight cancer - and helped transform bold scientific ideas into treatments. We fund breakthrough research at every stage, from fundamental immunology to clinical translation. Our global ecosystem supports young investigators, accelerates high-risk, high-reward ideas, and promotes collaboration between academia, biotech, and industry. Our mission is to create a world immune to cancer by driving scientific discovery, accelerating collaboration, and turning breakthroughs into life-saving treatments. Our work bridges the gap between discovery and patient impact, ensuring that scientific innovation translates into real-world treatments. šDiscover how CRI is fueling discoveries: cancerresearch.org š¬ Join our scientific community: fellowships, grants, and global collaboration opportunities š¢ Follow us for updates on research breakthroughs, inspiring patient stories, and funding announcements CRI welcomes your comments and community participation, but reminds you to be careful about posting sensitive information about yourself or others. CRI is not responsible for the use, reproduction, or distribution of publicly posted information, and by posting such information you hereby indemnify and release CRI from any liability arising from such disclosure.
Verified activity
Signals from Cancer Research Institute (CRI)
3 published signals
Capital & Finance
Cancer Research Institute (CRI) made its largest grantmaking investment to date in FY 2025ā26, totaling $34.4 million in new funding supporting 93 awards across 50 institutions, 17 U.S. states, and five countries.
Reported by Cancer Research Institute (CRI)
Capital & Finance
Cancer Research Institute (CRI) committed $34.4 million in new funding across 93 awards in FY2026, marking its largest grantmaking year ever.
Reported by Alicia Zhou, PhD
Presence & Recognition
Cancer Research Institute (CRI) announced that founder and managing partner of Yosemite, Reed Jobs, will receive the 2026 Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research.
Reported by Cancer Research Institute (CRI)